Recent Quotes (30 days)

You have no recent quotes
chg | %

Titan Medical Inc.  

(Public, CVE:TMD)   Watch this stock  
Find more results for TMD
Sep 29 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.38 - 2.76
Open     -
Vol / Avg. 0.00/48,846.00
Mkt cap 249.34M
P/E     -
Div/yield     -
EPS -0.20
Shares 101.80M
Beta 0.05
Inst. own     -
Nov 6, 2017
Q3 2017 Titan Medical Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Sep 11, 2017
Titan Medical Inc at Rodman & Renshaw Global Investment Conference
Aug 8, 2017
Q2 2017 Titan Medical Inc Earnings Release

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -80.62% -232.32%
Return on average equity -2815.92% -25444.28%
Employees 7 -
CDP Score - -


170 University Ave Suite 1000
+1-416-5487522 (Phone)

Website links


Titan Medical Inc. is a Canada-based company engaged in developing robotic surgical system for use in connection with minimally invasive surgery (MIS) (surgery without large incisions). The Company is developing the SPORT (Single Port Orifice Robotic Technology) Surgical System, a single-port/single-incision robotic surgical system to provide tele-operation (remote surgery) capabilities. The SPORT Surgical System comprises a surgeon-controlled robotic platform (patient cart) that includes a three dimensional (3D) high definition vision system and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an ergonomic interface to the robotic platform and also provides a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT Surgical System is also being developed to allow for data collection and analytics that could be utilized by the surgeon and/or operation room teams.

Officers and directors

Martin C. Bernholtz Chairman of the Board
David J. McNally President, Chief Executive Officer, Director
Age: 54
Stephen D. Randall Chief Financial Officer, Secretary
Perry A. Genova Ph.D. Vice President - Research & Development
John E. Barker Director
Age: 67
Bruce Gilles Wolff M.D. Independent Director